Sunday, 31 December 2017

Piper Jaffray Initiates “Buy” Rating for Bioverativ Inc (BIVV) With a $71.0 Price Target

  1. Piper Jaffray Initiates “Buy” Rating for Bioverativ Inc (BIVV) With a $71.0 Price Target  Weekly Register
  2. Bioverativ (NASDAQ:BIVV) Earning Somewhat Positive Press Coverage, Analysis Finds  Dispatch TribunalFull coverage
at

No comments:

Post a Comment